BioSpace

Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events

Patients had adverse events after receiving a Fresenius Kabi medicine that experienced manufacturing deviations.

Por BioSpace

1 minuto de lectura
Compartir
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events
Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse events

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas